Neumora Therapeutics, Inc. (NMRA) Stock Analysis

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $3.55
• Market Cap: $587.99M
• EPS: $-1.47
• 52-Week High: $3.65
• 52-Week Low: $0.61

Market Sentiment

Neumora Therapeutics, Inc. currently has a Neutral sentiment score of -0.08.

About Neumora Therapeutics, Inc.

Neumora Therapeutics, Inc. is a clinical-stage biopharmaceutical company based in Watertown, Massachusetts, dedicated to the development of transformative therapies for neuropsychiatric and neurodegenerative disorders. The company is focused on addressing significant unmet medical needs by leveraging cutting-edge science and technology to innovate treatment strategies targeted at critical biological pathways associated with complex brain diseases. With a robust pipeline of novel compounds, Ne...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for Neumora Therapeutics, Inc. and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does NMRA pay dividends?

Neumora Therapeutics, Inc. (NMRA) does not currently pay a regular dividend.

What is NMRA's market cap?

Neumora Therapeutics, Inc. (NMRA) has a market capitalization of $587.99M with a current stock price of $3.55.